Japanese anti-clotting drug Savaysa gets FDA approval
The US Food and Drug Administration (FDA) has given green signal to drug Savaysa (edoxaban) to lower the risk of stroke and systemic embolism as well as prevent the[…]
The US Food and Drug Administration (FDA) has given green signal to drug Savaysa (edoxaban) to lower the risk of stroke and systemic embolism as well as prevent the[…]